ANKRD30A (ankyrin repeat domain 30A)

2003-06-01 Affiliation

Identity

HGNC

ANKRD30A

LOCATION

10p11.21

LOCUSID

91074

ALIAS

NY-BR-1

FUSION GENES

Show Gene Fusions

Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool

Other Information

Locus ID:

NCBI: 91074
MIM: 610856
HGNC: 17234
Ensembl: ENSG00000148513

Variants:

dbSNP: 91074
ClinVar: 91074
TCGA: ENSG00000148513
COSMIC: ANKRD30A

RNA/Proteins

Gene ID	Transcript ID	Uniprot
ENSG00000148513	ENST00000361713	R4GNA2
ENSG00000148513	ENST00000374660	Q5W026
ENSG00000148513	ENST00000602533	R4GNA2
ENSG00000148513	ENST00000611781	Q9BXX3

Expression (GTEx)

Adipose - Subcutaneous

Adipose - Visceral

Adrenal Gland

Artery - Aorta

Artery - Tibial

Bladder

Brain - Amygdala

Brain - Anterior cingulate cortex

Brain - Caudate

Brain - Cerebellar Hemisphere

Brain - Cerebellum

Brain - Cortex

Brain - Frontal Cortex

Brain - Hippocampus

Brain - Hypothalamus

Brain - Nucleus accumbens

Brain - Putamen

Brain - Spinal cord

Brain - Substantia nigra

Breast - Mammary Tissue

Cells - Cultured fibroblasts

Cells - EBV - transformed lymphocytes

Cervix - Ectocervix

Cervix - Endocervix

Colon - Sigmoid

Colon - Transverse

Esophagus - Gastroesophageal Junction

Esophagus - Mucosa

Esophagus - Muscularis

Fallopian Tube

Heart - Atrial Appendage

Heart - Left Ventricle

Kidney - Cortex

Kidney - Medulla

Liver

Lung

Minor Salivary Gland

Muscle - Skeletal

Nerve - Tibial

Ovary

Pancreas

Pituitary

Prostate

Skin - Not Sun Exposed

Skin - Sun Exposed

Small Intestine - Terminal Ileum

Spleen

Stomach

Testis

Thyroid

Uterus

Vagina

Whole Blood

References

Pubmed ID	Year	Title	Citations
31786890	2019	A four-gene expression-based signature predicts the clinical outcome of melanoma.	3
31786890	2019	A four-gene expression-based signature predicts the clinical outcome of melanoma.	3
29116378	2018	Preferential expression of NY-BR-1 and GATA-3 in male breast cancer.	0
29116378	2018	Preferential expression of NY-BR-1 and GATA-3 in male breast cancer.	0
27863482	2016	In silico SNP analysis of the breast cancer antigen NY-BR-1.	2
27863482	2016	In silico SNP analysis of the breast cancer antigen NY-BR-1.	2
26415367	2015	NY-BR-1 Antigen Expression and anti-NY-BR-1 IgG in Egyptian Breast Cancer Patients: Clinicopathological and Prognostic Significance.	0
26415367	2015	NY-BR-1 Antigen Expression and anti-NY-BR-1 IgG in Egyptian Breast Cancer Patients: Clinicopathological and Prognostic Significance.	0
23731661	2013	Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications.	22
23731661	2013	Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications.	22
18041742	2008	Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts.	7
18041742	2008	Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts.	7
17330232	2007	The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer.	12
17536312	2007	NY-BR-1 is a differentiation antigen of the mammary gland.	11
17330232	2007	The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer.	12

Citation

Dessen P

ANKRD30A (ankyrin repeat domain 30A)

Atlas Genet Cytogenet Oncol Haematol. 2003-06-01

Online version: http://atlasgeneticsoncology.org/gene/41596/js/humanGenome